Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Small

Showing results (751-760 of 765) with videos related to

Pageof 77
Sort By:
Neurogenetics|December 14, 1999
The alpha-synuclein gene is not a major risk factor in familial Parkinson diseaseW K Scott, L H Yamaoka, J M Stajich, et al.
Annals of Neurology|May 6, 2003
Parkin mutations and susceptibility alleles in late-onset Parkinson's diseaseSofia A Oliveira, William K Scott, Eden R Martin, et al.
JAMA|November 22, 2001
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcomeD H Silverman, G W Small, C Y Chang, et al.
ESMO Open|March 11, 2026
A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) studyS Y Ryu, B H Nam, M H Kim, et al.
American Journal of Human Genetics|March 6, 2003
Mitochondrial polymorphisms significantly reduce the risk of Parkinson diseaseJoelle M van der Walt, Kristin K Nicodemus, Eden R Martin, et al.
Archives of Neurology|July 23, 2003
Association study of Parkin gene polymorphisms with idiopathic Parkinson diseaseSofia A Oliveira, William K Scott, Martha A Nance, et al.
Nature Genetics|May 13, 1999
An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer diseaseE A Rogaeva, S Premkumar, J Grubber, et al.
Neurology|April 12, 2003
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's diseaseJ M van der Walt, E R Martin, W K Scott, et al.
JAMA|November 17, 2001
Complete genomic screen in Parkinson disease: evidence for multiple genesW K Scott, M A Nance, R L Watts, et al.
American Journal of Human Genetics|October 15, 2022
Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathyStijn Van de Sompele, Kent W Small, Munevver Burcu Cicekdal, et al.
Pageof 77

Showing results (751-760 of 765) with videos related to

Sort By:
Pageof 77
Neurogenetics|December 14, 1999
The alpha-synuclein gene is not a major risk factor in familial Parkinson diseaseW K Scott, L H Yamaoka, J M Stajich, et al.
Annals of Neurology|May 6, 2003
Parkin mutations and susceptibility alleles in late-onset Parkinson's diseaseSofia A Oliveira, William K Scott, Eden R Martin, et al.
JAMA|November 22, 2001
Positron emission tomography in evaluation of dementia: Regional brain metabolism and long-term outcomeD H Silverman, G W Small, C Y Chang, et al.
ESMO Open|March 11, 2026
A randomized phase III clinical trial of weekly versus tri-weekly cisplatin-based chemoradiotherapy for locally advanced cervical cancer: results of the TACO (GCIG/KGOG 1027/THAI 2012) studyS Y Ryu, B H Nam, M H Kim, et al.
American Journal of Human Genetics|March 6, 2003
Mitochondrial polymorphisms significantly reduce the risk of Parkinson diseaseJoelle M van der Walt, Kristin K Nicodemus, Eden R Martin, et al.
Archives of Neurology|July 23, 2003
Association study of Parkin gene polymorphisms with idiopathic Parkinson diseaseSofia A Oliveira, William K Scott, Martha A Nance, et al.
Nature Genetics|May 13, 1999
An alpha-2-macroglobulin insertion-deletion polymorphism in Alzheimer diseaseE A Rogaeva, S Premkumar, J Grubber, et al.
Neurology|April 12, 2003
Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's diseaseJ M van der Walt, E R Martin, W K Scott, et al.
JAMA|November 17, 2001
Complete genomic screen in Parkinson disease: evidence for multiple genesW K Scott, M A Nance, R L Watts, et al.
American Journal of Human Genetics|October 15, 2022
Multi-omics approach dissects cis-regulatory mechanisms underlying North Carolina macular dystrophy, a retinal enhanceropathyStijn Van de Sompele, Kent W Small, Munevver Burcu Cicekdal, et al.
Pageof 77